SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Faeth Therapeutics Signs Roche Collaboration on Breast Cancer Study

Faeth will sponsor and run a Phase 1b/2 study evaluating PIKTOR with Roche’s giredestrant in HR+/HER2- breast cancer.

FTH

Related stories